Geode Capital Management
BIOA

Geode Capital Management’s BioAge Labs BIOA Stock Holding History

Geode Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.6M Buy
1,004,264
+254,998
+34% +$4.61M ﹤0.01% 2026
2026
Q1 		$13.1M Buy
749,266
+157,889
+27% +$3.04M ﹤0.01% 2219
2025
Q4 		$7.83M Buy
591,377
+28,646
+5% +$254K ﹤0.01% 2528
2025
Q3 		$3.31M Buy
562,731
+109,276
+24% +$512K ﹤0.01% 2984
2025
Q2 		$1.87M Buy
453,455
+171,426
+61% +$691K ﹤0.01% 3167
2025
Q1 		$1.06M Buy
282,029
+25,034
+10% +$116K ﹤0.01% 3290
2024
Q4 		$1.49M Buy
+256,995
New +$4.43M ﹤0.01% 3233

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Geode Capital Management's BIOA Position: Q2 2026 in Review

Geode Capital Management increased its BioAge Labs (BIOA) stake by 34% in Q2 2026, buying an estimated $4.61M and bringing the position to 1,004,264 shares worth $24.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2026.

Geode Capital Management first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Geode Capital Management held 1,004,264 shares of BioAge Labs worth $24.6M as of Q2 2026.
  • Geode Capital Management bought 254,998 BioAge Labs shares in Q2 2026, an estimated $4.61M.
  • BioAge Labs made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2026 holding.
  • Geode Capital Management first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.